Sino Biological Inc
SZSE:301047
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
54.7
89.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Sino Biological Inc
Sino Biological Inc
Change in Working Capital
Sino Biological Inc
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sino Biological Inc
SZSE:301047
|
Change in Working Capital
-¥307.9m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Change in Working Capital
-¥12.8B
|
CAGR 3-Years
-278%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Change in Working Capital
-¥3.9B
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Change in Working Capital
-¥1.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-22%
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Change in Working Capital
-¥3.7B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-33%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Change in Working Capital
-¥496.4m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Sino Biological Inc
Glance View
Sino Biological Inc. provides protein, antibody and gene products. The company is headquartered in Beijing, Beijing and currently employs 495 full-time employees. The company went IPO on 2021-08-16. The firm's main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services. The firm operates in the domestic market and overseas markets.
See Also
What is Sino Biological Inc's Change in Working Capital?
Change in Working Capital
-307.9m
CNY
Based on the financial report for Dec 31, 2023, Sino Biological Inc's Change in Working Capital amounts to -307.9m CNY.
What is Sino Biological Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-32%
Over the last year, the Change in Working Capital growth was -43%. The average annual Change in Working Capital growth rates for Sino Biological Inc have been -27% over the past three years , -32% over the past five years .
You don't have any saved screeners yet
